USA News Hub

In 2021, due to the Covid-19 pandemic, the Biden administration said providers could prescribe mifepristone during telemedicine appointments. The administration made that change permanent later the same year. If the Supreme Court rules in favor of the anti-abortion group, it could undo all of those FDA-approved changes.

As arguments began Tuesday, Solicitor General Elizabeth Prelogar, who represents the FDA, argued that the plaintiffs did not have standing to bring the case in the first place. Their arguments of potential harm, she said, “rely on a long chain of remote contingencies.” The circumstances that would cause anti-abortion doctors harm are unlikely to arise often enough to merit the lawsuit.

In fact, the initial lawsuit and ruling against mifepristone cited multiple bogus studies that either cherry-picked results from a small sample pool or were based on such faulty data that they were retracted altogether.